Thermosome Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 7

Thermosome General Information

Description

Developer of a drug development platform designed to improve antitumor responses in cancer treatment. The company's platform leverages a proprietary drug delivery technology, which exploits a novel mechanism of action called intravascular drug release that is used to treat locally advanced solid tumors with targeted chemotherapy, enabling patients to begin cancer treatment quickly with low side effects and increased efficacy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Am Klopferspitz 19
  • 82152 Planegg
  • Germany
+49 089
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Am Klopferspitz 19
  • 82152 Planegg
  • Germany
+49 089

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Thermosome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) Completed Clinical Trials - Phase 1
2. Early Stage VC 31-Aug-2016 Completed Clinical Trials - Phase 1
1. Grant 06-Apr-2016 $3.03M Completed Startup
To view Thermosome’s complete valuation and funding history, request access »

Thermosome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug development platform designed to improve antitumor responses in cancer treatment. The company's plat
Drug Discovery
Planegg, Germany
11 As of 2026

Lexington, MA
 

Lawrenceville, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Thermosome Competitors (54)

One of Thermosome’s 54 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
Imunon Corporation Lawrenceville, NJ
Pure MHC Formerly VC-backed Austin, TX
iOmx Therapeutics Venture Capital-Backed Munich, Germany
MaveriX Oncology Venture Capital-Backed Palo Alto, CA
You’re viewing 5 of 54 competitors. Get the full list »

Thermosome Patents

Thermosome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4527380-A1 Lipid nanoparticles Inactive 19-Sep-2023
EP-4780425-A1 Lipid nanoparticles Pending 19-Sep-2023
JP-2026534185-A Lipid nanoparticles Pending 19-Sep-2023
WO-2025061856-A1 Lipid nanoparticles Inactive 19-Sep-2023
AU-2024345757-A1 Lipids containing an oligoglycerol group Pending 19-Sep-2023 C07C219/08
To view Thermosome’s complete patent history, request access »

Thermosome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thermosome Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arnika Beteiligungen Family Office Family Office Minority
Bayern Kapital Venture Capital Minority
Bundesministerium für Bildung und Forschung Government Minority
High-Tech Gründerfonds Venture Capital Minority
German Ministry of Education and Research Government
You’re viewing 5 of 7 investors. Get the full list »

Thermosome FAQs

  • When was Thermosome founded?

    Thermosome was founded in 2015.

  • Where is Thermosome headquartered?

    Thermosome is headquartered in Planegg, Germany.

  • What is the size of Thermosome?

    Thermosome has 11 total employees.

  • What industry is Thermosome in?

    Thermosome’s primary industry is Drug Discovery.

  • Is Thermosome a private or public company?

    Thermosome is a Private company.

  • What is Thermosome’s current revenue?

    The current revenue for Thermosome is .

  • How much funding has Thermosome raised over time?

    Thermosome has raised $5.15M.

  • Who are Thermosome’s investors?

    Arnika Beteiligungen Family Office, Bayern Kapital, Bundesministerium für Bildung und Forschung, High-Tech Gründerfonds, and German Ministry of Education and Research are 5 of 7 investors who have invested in Thermosome.

  • Who are Thermosome’s competitors?

    Voyager Therapeutics, Imunon, Pure MHC, iOmx Therapeutics, and MaveriX Oncology are some of the 54 competitors of Thermosome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process